Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NANOTRAC

Financiado

Cerrado

Tracing the Intracellular Fate of Anticancer Nanomedicines

Nanomedicines are defined as specifically engineered, nanosized drugs and drug delivery systems that are comprised of multiple components. For example, polymer-drug conjugates and drug-protein conjugates are emerging as promising... ver más

28/02/2017

UNIVERSITY OF STRA...

100K€

Presupuesto del proyecto: 100K€

Líder del proyecto

UNIVERSITY OF STRATHCLYDE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-02-28 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UNIVERSITY OF STRATHCLYDE

0.00€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NANOTHERAPY A Novel Nanocontainer drug carrier for targeted treatment of... 150K€ Cerrado

MyNano Towards the design of Personalised Polymer based Combination... 2M€ Cerrado

BES-2011-049198 DESARROLLO DE VECTORES NANOPARTICULADOS NO VIRALES PARA TRAN... 41K€ Cerrado

NANOSIRNA Transfection Ability and Intracellular Pathway of LbL Nanost... 49K€ Cerrado

PID2019-109450RB-I00 POLIMEROS SUPRAMOLECULARES DIRIGIDOS AL MICROAMBIENTE TUMORA... 97K€ Cerrado

BIO2013-41019-P INGENIERIA DE NANOPARTICULAS PROTEICAS PARA LA ENTREGA DIRIG... 151K€ Cerrado

Líder del proyecto

UNIVERSITY OF STRATHCLYDE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 100K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Nanomedicines are defined as specifically engineered, nanosized drugs and drug delivery systems that are comprised of multiple components. For example, polymer-drug conjugates and drug-protein conjugates are emerging as promising approaches to treating a number of diseases, including cancer. The payloads of these nanomedicines differ widely. However, when targeting cancer, there is a universal requirement to reach the tumour microenvironment and often to deliver the payload to a specific intracellular compartment in order to yield the desired therapeutic effect. The goal of this proposal is to develop two complementary approaches that showcase the manufacturing of functionalised biopolymer-based nanoparticles and their subsequent biological evaluation in relation to cellular and subcellular trafficking in the tumour microenvironment. To achieve this goal, I propose two main aims. Aim 1 is to generate drug-loaded silk nanoparticles that can be readily functionlised to target specific cells and cellular compartments. I hypothesise that by using functionalised silk nanoparticles, it will be possible to target and deliver a therapeutic payload to cancer cells, which will lead to improved clinical outcomes in vivo. Aim 2 is to establish a repertoire of subcellular fractionation techniques in order to quantitatively describe the intracellular fate of nanomedicines in vitro and in vivo. I hypothesise that in particular, subcellular fractionation methods will allow a better understating of the fate of nanoparticles in tumour cells and their subsequent intracellular trafficking. Taken together, these studies will demonstrate an integrated approach to the development of next-generation nanomedicines. This proposal provides the drug delivery field with a novel nanoparticle system and a unique toolbox for the cellular tracing of nanomedicines for the wider scientific community.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores